Cytokinetics Inc. buy Royal Bank of Canada
Start price
06.05.26
/
50%
€62.44
Target price
06.05.27
-
Performance (%)
20.53%
Price
19:11
€75.26
Summary
This prediction is currently active. The prediction currently has a performance of 20.53%. This prediction currently runs until 06.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 5.079% | 5.079% |
| iShares Core DAX® | -1.358% | -2.165% |
| iShares Nasdaq 100 | -3.700% | -1.162% |
| iShares Nikkei 225® | -2.512% | 7.930% |
| iShares S&P 500 | -1.662% | -0.698% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
112.86%
08.05.26
08.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25